Cargando…
The trans-omics landscape of COVID-19
The outbreak of coronavirus disease 2019 (COVID-19) is a global health emergency. Various omics results have been reported for COVID-19, but the molecular hallmarks of COVID-19, especially in those patients without comorbidities, have not been fully investigated. Here we collect blood samples from 2...
Ejemplares similares
-
Longitudinal multi-omics transition associated with fatality in critically ill COVID-19 patients
por: Sun, Chaoyang, et al.
Publicado: (2021) -
BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages
por: Li, Xi, et al.
Publicado: (2020) -
Role of Dicer as a prognostic predictor for survival in cancer patients: a systematic review with a meta-analysis
por: Shan, Wanying, et al.
Publicado: (2016) -
KCNN4 and S100A14 act as predictors of recurrence in optimally debulked patients with serous ovarian cancer
por: Zhao, Haiyue, et al.
Publicado: (2016) -
HSP27 Knockdown Increases Cytoplasmic p21 and Cisplatin Sensitivity in Ovarian Carcinoma Cells
por: Lu, Hao, et al.
Publicado: (2016)